Skip to main content
OpenTrials

Clinical trial condition

Ovarian Diseases

Explore clinical trials studying Ovarian Diseases. Study availability and eligibility vary by location and protocol.

3,395 public trials 656 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Diseases trial results

Recruiting

A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

NCT07306559

Conditions
Adnexal Diseases, Advanced Relapsed or Refractory Endometrial Cancer, Advanced Relapsed or Refractory Germ Cell Tumours, +18 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Indiana University Indianapolis, Indiana, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
View all 13 locations
View Trial Details
Recruiting

DESTINY-PANTUMOUR04

NCT07124000

Conditions
Adenocarcinoma, Adenocarcinoma (NOS), Adnexal Diseases, +116 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Bullhead City, Arizona, United States
  • Research Site Casa Grande, Arizona, United States
  • Research Site San Diego, California, United States
View all 18 locations
View Trial Details
Recruiting

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

NCT04291612

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +22 more
Locations
  • Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States
  • Miami Cancer Institute Baptist Health South Florida Miami, Florida, United States
  • ADVENTHEALTH (Data collection only) Orlando, Florida, United States
  • Mayo Clinic (Data Collection and Data Analysis) Rochester, Minnesota, United States
View all 18 locations
View Trial Details
Recruiting

Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer

NCT04918186

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • The University of Chicago Medical Center Chicago, Illinois, United States
  • BCCA - Kelowna Kelowna, British Columbia, Canada
  • BCCA - Vancouver Vancouver, British Columbia, Canada
  • Odette Cancer Centre Toronto, Ontario, Canada
View Trial Details
Recruiting

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

NCT04751435

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +38 more
Locations
  • Kings County Hopsital Center Brooklyn, New York, United States
  • Queens Cancer Center of Queens Hospital Jamaica, New York, United States
  • Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities) New York, United States
  • Jamaica Hospital Medical Center (Data Collection Only) Richmond Hill, New York, United States
View Trial Details
Recruiting

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

NCT07218809

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site La Jolla, California, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 299 locations
View Trial Details
Recruiting

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

NCT07023627

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Usa Health Mitchell Cancer Institute Mobile, Alabama, United States
  • University of California, Los Angeles Medical Center Los Angeles, California, United States
  • Scripps Healthscripps Mercy Hospital Prebys Cancer Center San Diego, California, United States
  • Medstar Georgetown University Hospital Washington D.C., District of Columbia, United States
View all 74 locations
View Trial Details
Recruiting

Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer

NCT07564141

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
Locations
  • Danbury Hospital Danbury, Connecticut, United States
  • ProHealth Care Inc Waukesha, Wisconsin, United States
View Trial Details

Related conditions